Nanoencapsulated Doxorubicin Prevents Mucositis Development in Mice
Doxorubicin (DOX), a chemotherapy drug successfully used in the therapy of various types of cancer, is currently associated with the mucositis development, an inflammation that can cause ulcerative lesions in the mucosa of the gastrointestinal tract, abdominal pain and secondary infections. To incre...
Saved in:
Main Authors: | Cristiane M. Pinto (Author), Laila S. Horta (Author), Amanda P. Soares (Author), Bárbara A. Carvalho (Author), Enio Ferreira (Author), Eduardo B. Lages (Author), Lucas A. M. Ferreira (Author), André A. G. Faraco (Author), Helton C. Santiago (Author), Gisele A. C. Goulart (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Nanoencapsulation of Pomegranate Extract to Increase Stability and Potential Dermatological Protection
by: Lucía Yepes-Molina, et al.
Published: (2021) -
Development of a brazilian nanoencapsulated drug for schistosomiasis treatment
by: Laís Bastos da Fonseca, et al.
Published: (2013) -
New Strategies for Stroke Therapy: Nanoencapsulated Neuroglobin
by: Santos Blanco, et al.
Published: (2022) -
Controlled-release nanoencapsulating microcapsules to combat inflammatory diseases
by: Baek JS, et al.
Published: (2017) -
Microencapsulation and Nanoencapsulation Using Supercritical Fluid (SCF) Techniques
by: Soon Hong Soh, et al.
Published: (2019)